Observational studyScientific reports2026
Plasma fatty acid profiles and coronary artery disease burden assessed by coronary CT angiography: an observational study.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerotic coronary artery disease (CAD) remains a leading cause of death globally, and individual susceptibility is not fully explained by standard risk factors. The role of plasma fatty acid profiles in relation to imaging-defined CAD burden remains less well established. We performed a cross-sectional cohort analysis of 1,002 participants undergoing coronary computed tomographic angiography (CCTA), with blood samples collected immediately prior to contrast administration. Plasma fatty acids were quantified as a percentage of total plasma fatty acids and evaluated for associations with CAD burden, including coronary artery calcium score (CACS), CACS percentile, Gensini score, soft plaque score, and atrial fibrillation (AF). Associations were assessed using multivariate logistic regression, adjusting for age, sex, and cardiovascular risk factors. Higher plasma omega-6 levels were inversely associated with CACS (CAC+; odds ratio [OR] = 0.93, 95% confidence interval [CI] = 0.90–0.97) with similar inverse associations observed for Gensini and soft plaque scores. In contrast, monounsaturated (CAC + OR = 1.09, 95% CI = 1.03–1.15) and saturated fatty acids (CAC + OR = 1.08, 95% CI = 1.04–1.12) were positively associated with CAD burden. No consistent associations were observed with self-reported atrial fibrillation after multivariable adjustment. Plasma omega-6 fatty acids demonstrated inverse associations with imaging-defined CAD burden, suggesting a potential protective role that warrants investigation in longitudinal studies. Saturated and monounsaturated fatty acids were positively associated with CAD, aligning with prior evidence of their atherogenic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.